link to article

Reducing Cardiac Risks for Diabetics through Chelation Therapy

Chelation therapy was developed in the 1930s and was designed to remove heavy metals from the blood of severely metal-poisoned patients. In 2012, findings from the Trial to Assess Chelation Therapy (TACT) demonstrated benefits from chelation, particularly in diabetic patients with heart disease. The National Institutes of Health is supporting a second trial, TACT2, to verify the benefits of chelation therapy in diabetic patients who have had a prior heart attack.

Read the full story.